当前位置:首页 > 股票大全 > 科伦药业 002422 财务分析

科伦药业财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

科伦药业(002422)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入6,219,417,41321,453,929,23715,743,097,21610,733,926,609
营业总成本4,767,842,90218,277,363,12213,469,903,9689,088,100,822
营业利润1,632,448,2043,654,143,1582,597,479,2761,877,565,596
利润总额1,624,795,1723,580,426,0502,545,795,2881,853,185,338
净利润1,285,801,4132,646,639,3622,143,029,8331,577,645,855
其他综合收益-845,212-60,842,21873,410,07687,050,521
综合收益总额1,284,956,2012,585,797,1442,216,439,9091,664,696,376
科伦药业(002422)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计19,208,487,06718,290,026,50217,673,464,21416,919,576,779
非流动资产合计18,467,971,29818,164,874,63818,286,456,10117,983,464,320
资产总计37,676,458,36536,454,901,14035,959,920,31534,903,041,099
流动负债合计9,692,236,6009,993,110,1939,537,321,29012,224,012,023
非流动负债合计2,111,769,4373,446,197,3814,215,413,2434,186,592,740
负债合计11,804,006,03713,439,307,57413,752,734,53316,410,604,763
归属于母公司股东权益合计22,260,402,45219,672,377,98918,882,722,03916,486,394,882
股东权益合计25,872,452,32823,015,593,56622,207,185,78218,492,436,336
负债和股东权益合计37,676,458,36536,454,901,14035,959,920,31534,903,041,099
科伦药业(002422)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计6,561,069,02627,053,848,79420,125,729,32713,689,744,746
经营活动现金流出小计5,282,305,91021,716,779,86315,873,578,48810,275,428,429
经营活动产生的现金流量净额1,278,763,1165,337,068,9314,252,150,8393,414,316,317
投资活动现金流入小计1,772,849,0226,027,299,9965,010,691,3323,026,098,155
投资活动现金流出小计1,102,215,2139,397,624,9866,825,360,2165,047,427,671
投资活动产生的现金流量净额670,633,809-3,370,324,990-1,814,668,884-2,021,329,516
筹资活动现金流入小计1,204,294,6836,676,527,2475,881,849,0933,205,755,836
筹资活动现金流出小计1,512,332,6058,735,292,9357,565,387,0755,439,710,729
筹资活动产生的现金流量净额-308,037,922-2,058,765,688-1,683,537,982-2,233,954,893
汇率变动对现金及现金等价物的影响1,810,6065,194,0001,241,08110,680,435
现金及现金等价物净增加额1,643,169,609-86,827,747755,185,054-830,287,657
期末现金及现金等价物余额6,231,493,7564,588,324,1475,430,336,9463,841,262,179
科伦药业002422相关数据
今日股市大盘指数